Advances in High Throughput Supercritical Fluid Chromatography

Advances in LC: bioanalytical method transfer

There are three main reasons for transferring from an existing bioanalytical assay to an alternative chromatographic method: speed, cost and sensitivity. These represent a challenge to the analyst in that there is an interplay between these three considerations and one factor is often improved at the expense of another. These three factors act as drivers to encourage technology development and support its uptake. The more recently introduced chromatographic technologies may show significant improvements against one of more of these factors relative to conventional 4.6-mm id reversed-phase HPLC. In this article, some of these new chromatographic approaches will be considered in terms of what they can offer the bioanalysts.

Exploring the complexity of oil sands process-affected water by high efficiency supercritical fluid chromatography/orbitrap mass spectrometry

RATIONALE

Approximately 1 billion m(3) of oil sands process-affected water (OSPW) is currently stored in tailings ponds in Northern Alberta, Canada. The dissolved organic compounds in OSPW have been termed a supercomplex mixture of bitumen-derived substances and continuing efforts to understand its underlying chemical composition are important for evaluating its environmental hazards.

METHODS

Packed column supercritical fluid chromatography (SFC) was applied to OSPW analysis for the first time. By combining four columns in series (each 25 cm × 4.6 mm I.D., 5.0 µm bare silica) approximately 80,000 plates were achieved on a 1 m column. Using a simple fixed restrictor, the SFC eluent was coupled directly to ultrahigh-resolution orbitrap mass spectrometry (SFC/Orbitrap-MS).

RESULTS

SFC/Orbitrap-MS, with positive and negative atmospheric pressure chemical ionization (APCI +/-), revealed the partial or full chromatographic separation of isomers for a wide array of chemical species, including naphthenic acids (Cn H2n + Z O2 ) and unknown sulfur- and nitrogen-containing molecules. For smaller compounds (e.g. naphthenic acids where n ≤10), or for larger structurally constrained compounds (e.g. C16 naphthenic acid with 9 double-bond equivalents), apparent baseline resolution of many isomers was possible. Isomer-specific MS/MS experiments furthermore allowed characterization of functional groups in novel species. For example, in APCI+ mode, up to 16 isomers of C6 H11 ON were revealed to have amide and amino functionalities.

CONCLUSIONS

This combination of high efficiency chromatography and ultra-high mass resolution detection resulted in a powerful method with capabilities for characterizing or 'fingerprinting' unknown species with little interference. The method has great promise for environmental monitoring and forensics in the oil sands region, as well as for further studies on the composition of dissolved organic compounds in OSPW.

Integrative biological analysis for neuropsychopharmacology

Although advances in psychotherapy have been made in recent years, drug discovery for brain diseases such as schizophrenia and mood disorders has stagnated. The need for new biomarkers and validated therapeutic targets in the field of neuropsychopharmacology is widely unmet. The brain is the most complex part of human anatomy from the standpoint of number and types of cells, their interconnections, and circuitry. To better meet patient needs, improved methods to approach brain studies by understanding functional networks that interact with the genome are being developed. The integrated biological approaches--proteomics, transcriptomics, metabolomics, and glycomics--have a strong record in several areas of biomedicine, including neurochemistry and neuro-oncology. Published applications of an integrated approach to projects of neurological, psychiatric, and pharmacological natures are still few but show promise to provide deep biological knowledge derived from cells, animal models, and clinical materials. Future studies that yield insights based on integrated analyses promise to deliver new therapeutic targets and biomarkers for personalized medicine.